tiprankstipranks
Sanofi to acquire rights to develop, commercialize aficamten from Corxel
PremiumThe FlySanofi to acquire rights to develop, commercialize aficamten from Corxel
1M ago
Cytokinetics price target raised to $82 from $80 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $82 from $80 at RBC Capital
1M ago
Cytokinetics opens enrollment for COMET-HF Phase 3 trial
Premium
The Fly
Cytokinetics opens enrollment for COMET-HF Phase 3 trial
2M ago
Cytokinetics, Bayer enter collaboration and license pact for aficamten in Japan
PremiumThe FlyCytokinetics, Bayer enter collaboration and license pact for aficamten in Japan
2M ago
Cytokinetics announces initiation of Phase 1 study of CK-089
Premium
The Fly
Cytokinetics announces initiation of Phase 1 study of CK-089
2M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
Premium
The Fly
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
2M ago
Cytokinetics reports Q3 EPS ($1.36), consensus ($1.25)
PremiumThe FlyCytokinetics reports Q3 EPS ($1.36), consensus ($1.25)
3M ago
Cytokinetics (CYTK) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Cytokinetics (CYTK) Q3 Earnings Cheat Sheet
3M ago
Cytokinetics to provide an update on cardiac myosin modulation programs
Premium
The Fly
Cytokinetics to provide an update on cardiac myosin modulation programs
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100